Amicus Therapeutics (NASDAQ:FOLD) Given New $15.00 Price Target at Bank of America
Amicus Therapeutics (NASDAQ:FOLD – Free Report) had its target price boosted by Bank of America from $13.00 to $15.00 in a research report released on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on FOLD. Needham & […]
18 Oct 11:45 · The Markets Daily